Pharma Journalist 8887 posts 0 comments

Otsuka Pharmaceutical Co., Ltd. has signed an asset purchase agreement with Swedish biotech firm Cantargia AB to acquire global rights to CAN10, a promising antibody drug candidate…
Read More...

Acumen Pharmaceuticals has entered into a strategic collaboration and licensing agreement with Japan-based JCR Pharmaceuticals to co-develop a next-generation Alzheimer’s disease…
Read More...

Navamedic ASA has officially completed its acquisition of DNE Pharma’s business, marking a major milestone in the company’s strategic expansion into the addiction treatment market. The…
Read More...

Secarna Pharmaceuticals and Vect-Horus have launched a strategic research collaboration to develop RNA-targeted therapeutics capable of crossing the blood-brain barrier (BBB) for…
Read More...

Transcend Therapeutics, a clinical-stage biotech focused on neuropsychiatric treatments, announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy…
Read More...

Merck Animal Health, a division of Merck & Co., Inc., announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO QUANTUM (fluralaner for extended-release injectable…
Read More...

Merck, known as MSD outside the U.S. and Canada, announced that it will acquire Verona Pharma plc in a $10 billion deal, strengthening its presence in the respiratory disease space. The…
Read More...

Indian pharmaceutical major Lupin Limited and pan-European drugmaker Zentiva Group have signed a license and supply agreement to commercialize Lupin’s biosimilar Certolizumab Pegol…
Read More...

AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI),announced an exclusive licensing agreement for IGI's lead…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully…
Read More...